VC  TPG Biotech

     Office Locations:

345 California Street, Suite 3300
San Francisco, CA 94104
Phone: 415-743-1500
Fax: 415-743-1501



  • Early
  • Expansion
  • Growth



  • Life Sciences & Healthcare
  • Medical Device



    TPG Biotech is the life science venture investment arm of TPG (see profile), a global private investment firm. TPG Biotech invests across life science sectors, geographies, company stages, and asset classes. Since 2002, the firm has invested over half a billion dollars in over forty life science businesses, spanning drug discovery, personalized diagnostic solutions, pharmaceutical services, medical devices, and industrial biotechnology.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Cayce Denton Vice President
    Eran Nadav Managing Director
    Fred Cohen Partner and Managing Director
    Geoff Duyk Partner and Managing Director
    Heather Preston Partner and Managing Director


    Recent Funding Events (trailing 12 months):







      Carisma Therapeutics



      Series A


    Portfolio companies include:

        web link

      Alder BioPharmaceuticals
        web link

      Alphabet Energy
        web link

        web link

        web link

        web link

        web link

      Avidity NanoMedicines
        web link

      Axcan Pharma
        web link

      BioCryst Pharmaceuticals
        web link

        web link

      Carisma Therapeutics
        web link

      Collegium Pharma
        web link

        web link

      CSI Replidyne
        web link

        web link

        web link

      Elevance Renewable Sciences
        web link

      Elevation Pharmaceuticals
        web link

      Engage Therapeutics
        web link

        web link

      Five Prime Therapeutics
        web link

        web link

      Galleon Pharmaceuticals
        web link

      Genoa Pharmaceuticals
        web link

        web link

      Genomic Health
        web link

      IMS Health
        web link

        web link

        web link

        web link

      PatientSafe Solutions
        web link

        web link

      Rapid Micro Biosystems
        web link

        web link

        web link

      Trevi Therapeutics
        web link

      Unchained Labs
        web link

        web link

      WIL Research Laboratories
        web link


    Recent News: